HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathological findings in the iris of dapsone treated leprosy patients.

Abstract
From 43 Nepalese leprosy patients skin smear negative, and treated with dapsone (diamino diphenyl sulphone), and without any sign of active leprosy or iritis, specimens from iridectomy during cataract surgery were studied histopathologically. Of 49 iris specimens only six (12%) were found to be without any histopathological change. Atrophy of the iris stroma was seen in 63% and neovascularisation in 6% of all cases. In 16% in which the dilator muscle could be detected, it was atrophic, and in 11% the pigmented epithelium was thinned and atrophic. Cellular inflammatory infiltrations were seen in 88% of all specimens. They were mostly slight in eyes which before operation had been without posterior synechiae of the iris. In most of the eyes in which posterior synechiae had been present moderate or heavy inflammatory cell infiltrates composed of lymphocytes and plasma cells, often associated with macrophages, neutrophils, or eosinophils, were found. In five iris specimens acid fast bacilli were present. This raises the question whether these can survive systemically despite dapsone chemotherapy in the iris, thus leading to dapsone-resistant leprosy and to recurrent iritis.
AuthorsF Brandt, H M Zhou, Z R Shi, N Rai, L Thuladar, H Pradhan
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 74 Issue 1 Pg. 14-8 (Jan 1990) ISSN: 0007-1161 [Print] England
PMID1689588 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dapsone
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Atrophy
  • Dapsone (therapeutic use)
  • Female
  • Humans
  • Iris (blood supply, microbiology, pathology)
  • Iritis (etiology, microbiology, pathology)
  • Leprosy (complications, drug therapy, microbiology, pathology)
  • Male
  • Middle Aged
  • Mycobacterium leprae (isolation & purification)
  • Neovascularization, Pathologic (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: